What’s Next in Myeloma Research and Treatment?

Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of MinnesotaПодробнее

Replay: Discover the Latest Myeloma Research at ASH - Insights for Patients & FamiliesПодробнее

Multiple Myeloma Research And Patient Care: Where Have We Been And Where Are We Going?Подробнее

Top Myeloma Research at ASH 2023 from a Patient PerspectiveПодробнее

Developing Research and New Myeloma Treatment OptionsПодробнее

Myeloma UK London Infoday 2024 | Research & Developments in MyelomaПодробнее

Top Myeloma Research Presented at ASCO & EHA 2024Подробнее

Breakthroughs in Myeloma Research: What is the IMF's Black Swan Research Initiative's Impact?Подробнее

Kenneth C. Anderson - Multiple myeloma cured in 2030: what are the next steps?Подробнее

Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the HorizonПодробнее

Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of ActionПодробнее

What Questions are Current Myeloma Trials NOT Answering | Invited Talk to UK Myeloma Research DayПодробнее

Top Myeloma Research Presented at ASH 2022Подробнее

First-Line or Frontline Therapy Options In Multiple Myeloma | 2023 IMF Patient and Family SeminarПодробнее

Update in Multiple MyelomaПодробнее

Multiple Myeloma Precursor Conditions | Overview | Therapeutic InterventionПодробнее

Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer InstituteПодробнее

Multiple Myeloma in 2023: What Patients & Caregivers Need to Know Now! | The Patient StoryПодробнее

Myeloma Research – What’s new? / 2023 Myeloma WeekПодробнее